Quantinno Capital Management LP grew its stake in Genpact Limited (NYSE:G - Free Report) by 60.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 276,273 shares of the business services provider's stock after buying an additional 104,448 shares during the period. Quantinno Capital Management LP owned approximately 0.16% of Genpact worth $11,866,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of G. Coppell Advisory Solutions LLC grew its holdings in shares of Genpact by 529.5% during the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after purchasing an additional 503 shares during the last quarter. SRH Advisors LLC bought a new position in shares of Genpact during the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. grew its holdings in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the last quarter. GeoWealth Management LLC grew its holdings in shares of Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after purchasing an additional 583 shares during the last quarter. Finally, Manchester Capital Management LLC bought a new position in shares of Genpact during the 4th quarter valued at $38,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Genpact Stock Up 0.9%
NYSE G traded up $0.41 during trading hours on Friday, reaching $44.28. 2,286,869 shares of the company's stock traded hands, compared to its average volume of 1,368,521. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76. The firm has a market cap of $7.74 billion, a PE ratio of 15.59, a PEG ratio of 1.84 and a beta of 1.02. The firm has a 50-day simple moving average of $48.02 and a 200 day simple moving average of $47.19. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. Genpact's revenue was up 7.4% on a year-over-year basis. During the same period last year, the company posted $0.73 EPS. Sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Analysts Set New Price Targets
G has been the subject of several analyst reports. Mizuho increased their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Needham & Company LLC dropped their price target on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Robert W. Baird dropped their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $50.71.
Get Our Latest Analysis on Genpact
Insider Transactions at Genpact
In other Genpact news, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the acquisition, the director now owns 2,000 shares in the company, valued at $87,940. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.07% of the company's stock.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.